|
Charles Gonzalez on Drugs
Democrat
|
Voted YES on more funding for Mexico to fight drugs.
Congressional Summary:Merida Initiative to Combat Illicit Narcotics and Reduce Organized Crime Authorization Act:Provide assistance for Mexico for:- counternarcotics and countertrafficking;
- port & airport security to assist in controlling the Mexico-US and Mexico-Central America borders;
- intelligence gathering operational technology; and
- public security and law enforcement, including assistance to the National Council Against Addiction (CONADIC).
Proponent's argument to vote Yes:Rep. HOWARD BERMAN (D, CA-28): The drug crisis facing the US remains a top national security threat. This bill represents a new partnership with Mexico and Central American countries to face the immediate security threat of drug gangs, and help these neighbors build the capacity of their law enforcement agencies.
Opponent's argument to vote No:Rep. MICHAEL McCAUL (R, TX-10): We need a strategy on this side of the border: a two-pronged
Approach; a comprehensive strategy that deals not only with the Mexican side but with the US side. And for too long, our border sheriffs and our Border Patrol agents have been outmanned and outgunned. And if we are going to provide assistance to Mexico, it seems to me we ought to be providing assistance to our men and women on our side fighting this war every day.
Rep. TED POE (R, TX-2): I am concerned about drugs and violence on the border, but I am also concerned about corruption. In order to gain control of access corridors in the US, drug cartels are hiring hit men from an elite force in Mexico's military. This group is known as the "Zetas." Some of the Zetas are military deserters that may have been trained in the US. $1 billion in this bill would go to Mexico. And Mexico in its arrogance objects to any conditions we want to put on this money. The administration can offer us no assurance that our equipment and training won't be used against us and neither can Mexico.
Reference: Merida Initiative;
Bill HR.6028
; vote number 2008-H393
on Jun 10, 2008
End harsher sentencing for crack vs. powder cocaine.
Gonzalez co-sponsored ending harsher sentencing for crack vs. powder cocaine
A bill to target cocaine kingpins and address sentencing disparity between crack and powder cocaine.
Sponsor's introductory remarks: Sen. Biden: My bill will eliminate the current 100-to-1 disparity [between sentencing for crack vs. powder cocaine] by increasing the 5-year mandatory minimum threshold quantity for crack cocaine to 500 grams, from 5 grams, and the 10-year threshold quantity to 5,000 grams, from 50 grams, while maintaining the current statutory mandatory minimum threshold quantities for powder cocaine. It will also eliminate the current 5-year mandatory minimum penalty for simple possession of crack cocaine, the only mandatory minimum sentence for simple possession of a drug by a first time offender.
Drug use is a serious problem, and I have long supported strong antidrug legislation. But in addition to being tough, our drug laws should be rational and fair. My bill achieves the right balance. We have talked about the need to address this cocaine sentencing disparity for long enough. It is time to act.
Congressional Summary:
Increases the amount of a controlled substance or mixture containing a cocaine base (i.e., crack cocaine) required for the imposition of mandatory minimum prison terms for crack cocaine trafficking to eliminate the sentencing disparity between crack and powder cocaine.- Eliminates the five-year mandatory minimum prison term for first-time possession of crack cocaine.
- Increases monetary penalties for drug trafficking and for the importation and exportation of controlled substances.
Related bills: H.R.79, H.R.460, H.R.4545, S.1383, S.1685.
Source: Drug Sentencing Reform & Kingpin Trafficking Act (S.1711) 07-S1711 on Jun 27, 2007
Allow rehabilitated drug convicts get student loans.
Gonzalez co-sponsored allowing rehabilitated drug convicts get student loans
This bill amends the Higher Education Act of 1965 to repeal the provisions prohibiting persons convicted of drug offenses from receiving student financial assistance.
Source: Removing Impediments to Students Education (RISE) (H.R.5157) 08-HR5157 on Jan 29, 2008
Distribute sterile syringes to reduce AIDS and hepatitis.
Gonzalez signed Community AIDS and Hepatitis Prevention Act
To permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis.
Congress finds as follows:- Each year, approximately 12,000 Americans contract HIV/AIDS and approximately 19,000 Americans contract the hepatitis C virus directly or indirectly from sharing contaminated syringes.
- A 2005 comprehensive international review of the evidence of the effectiveness of syringe exchange programs in preventing HIV transmission shows that such programs reduce HIV transmission and are cost-effective.
- Research has shown that injection drug users who are referred to addiction treatment from syringe exchange programs are more likely to enter and remain in treatment.
- Research has shown that, by providing safe disposal of used injection equipment, syringe exchange programs significantly reduce the number of improperly discarded
syringes in the community, thereby reducing the exposure of police and others to dangers of blood-borne disease from accidental syringe sticks.
- Syringe exchange programs reduce the prevalence of HIV among injection drug users.
- Despite the scientific and public health consensus that syringe exchange programs reduce HIV and do not increase substance abuse, a ban on funding syringe exchange has been enacted as part of each Appropriations Act since 1998.
- The Public Health Service Act, as added by the Ryan White Comprehensive AIDS Resources Emergency Act of 1990, is subject to a statutory ban on funding needle exchange programs.
Notwithstanding any other provision of law, nothing shall prohibit the use of Federal funds to establish or carry out a program of distributing sterile syringes to reduce the transmission of bloodborne pathogens, including the human immunodeficiency virus (HIV) and viral hepatitis.
Source: HR 179 2009-H179 on Jan 6, 2009
Page last updated: Jun 09, 2012